Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 35.1B |
| Enterprise Value | 34.14B |
| P/E Ratio | 13.34 |
| PEG Ratio | -7.68 |
| Price/Sales Ratio | 4.33 |
| Price/Book Ratio | 3.87 |
| Enterprise/Revenue | 4.16 |
| Enterprise/EBITDA | 19.28 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.44 |
| Operating Margin | 0.49 |
AD
Management Effectiveness
| Return On Assets | 0.21 |
| Return On Equity | 0.27 |
Income Statement
| Revenue | 4.92B |
| Revenue/Share | 6.46 |
| Gross Profit | 3.64B |
| EBITDA | 2.61B |
| Net Income | 2.13B |
| Diluted EPS | 2.77 |
Balance Sheet
| Total Cash | 1.77B |
| Total Cash/Share | 2.3 |
| Total Debt | 57.84M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 2.16 |
| Book Value Per Share | 9.77 |
Price History
| 52-Week Change | 15.88 |
| 52-Week High | 50.97 |
| 52-Week Low | 31.68 |
| Moving Average 50 Days | 40.42 |
| Moving Average 200 Days | 43.63 |
Statistics
| Average Volume | 3.94M |
| Shares Outstanding | 570.09M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 3.73 |
| Trailing Annual Dividend Yield | 9.87 |
| Payout Ratio | 0.86 |
| Last Split Factor | 2:1 |
| Last Split Date | July 05, 2010 |
AD
